Swiss stocks - Factors to watch on June 17

Santhera Pharmaceuticals Holding AG

17/06/2020 05:51

ZURICH/BERLIN, June 17(Reuters) - Here are some of the main
factors that may affect Swiss stocks on Wednesday:
    
    NOVARTIS  NOVN.S 
    The U.S. Food and Drug Administration (FDA) said it had
approved Ilaris injection for treatment of active Still's
disease, including adult-onset Still's disease.  urn:newsml:reuters.com:*:nASA00TZY
    
    COMPANY STATEMENTS
    * Novartis  NOVN.S  said its Cosentyx drug had received the
FDA approval for new indication to treat active non-radiographic
axial spondyloarthritis.  urn:newsml:reuters.com:*:nASN00083Z
    * Santhera  SANN.S  said it completed a capital increase,
issuing 870,000 reserve shares  SANN.S 
    * Achiko  ACHI.S  announced a $4 million capital increase.
    * Blackstone Resources  BLS.S  said it had sold exploration
interests for 22 million Sfr.  urn:newsml:reuters.com:*:nASN00083M
    * Metall Zug  METN.S  said a scheduled for spin-off of V-Zug
had been less significantly affected by the impact of covid-19
pandemic.  urn:newsml:reuters.com:*:nFWN2DT0YJ

    
    ECONOMY
    No major economic data scheduled.
    

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))